View Post

High prevalence of HHV-6B & HPV in invasive pituitary adenomas

A recent study from investigators at Chongqing University in China explored the involvement of three viruses in the progression of pituitary adenomas (PA). The authors suggest that the HPV-16 and HHV-6 viruses activate the TLR3/ NF-kB signaling pathway which in turn contributes to the progression and proliferation of invasive pituitary adenomas.

View Post

Superinfection of HHV-6A in ciHHV6A patients with recurrent cardiac disease: a full genome analysis

A group led by Ursula Gompels from the London School of Hygiene & Tropical Medicine, University of London, did next generation sequencing on three ciHHV6A cardiac patients and found superinfections of HHV-6A in two of the three. They characterized the first full genome sequence of ciHHV-6A and demonstrated the inherited ciHHV6 genome was similar but distinct from known exogenous (community acquired) strains of HHV-6A .

View Post

HHV-6 & 7 potentiate CMV infection in transplant patients

A new study suggests that HHV-6 and HHV-7 are important co-factors for the development of CMV infection post-transplant in allogeneic hematopoietic stem cell transplantation patients. Additionally, the presence of HHV-7 and CMV together may result in more severe infections than either virus alone.

View Post

Brincidofovir fails Phase III CMV trial. Did physicians mistake diarrhea for GVHD?

Chimerix announced that the Phase III trial of brincidofovir has failed to meet its primary endpoint of suppressing CMV infection through week 24 after hematopoietic cell transplant (HCT) patients. Although the drug showed impressive suppression of CMV infections during the 14 week trial, infections soared during the 10-week observation period that followed. One theory presented by the company’s CEO is that physicians may have mistaken drug related diarrhea for GHVD and administered unnecessary steroids.

View Post

Philip Pellett wins Lifetime Achievement Award

Philip Pellett, PhD, a Professor and Interim Chair of Immunology and Microbiology at the Wayne State University School of Medicine, was awarded the HHV-6 Foundation’s Dharam Ablashi Lifetime Achievement Award at the 9th International Conference on HHV-6 & 7.

View Post

HHV-6 myocarditis, pericarditis following transplantation

A hematology group in Australia reported a case of biopsy-proven HHV-6 myocarditis post-hematopoietic stem cell transplantation (HSCT). he post-mortem exam confirmed dilated cardiomyopathy and focal changes consistent with viral myocarditis and cardiac tissue was positive for HHV-6 DNA by nested and quantitative PCR. Separately, A Japanese group reported a worman who developed pericarditis with over 10,000 copies/ml of HHV-6 DNA in the pericardial fluid, after a cord blood transplant.

View Post

HHV-6 induced Parkinsonism post-transplant

A group of researchers from Sao Paulo, Brazil reported the development of HHV-6 infection in the striatum of a 32-year-old man six weeks after allogeneic hematopoietic stem cell transplantation. This is the first reported case of HHV-6 infection affecting the striatum and presenting with Parkinsonism post-HSCT.